At a glance
- Originator Pharmacia Corporation
- Class Anti-ischaemics
- Mechanism of Action Calcium channel antagonists; Lipid peroxidation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 22 Jan 1997 No-Development-Reported for Cognition disorders in USA (Unknown route)
- 07 Dec 1994 Preclinical development for Cognition disorders in USA (Unknown route)